Thymosin Alpha 1 is an important immunomodulator, used in athletes and people under high stress. It helps maintain a balanced immune response, supports recovery and protects the body during an active training regimen.
This peptide helps the body to "tune" and coordinate its defensive responses so that it responds more organizedly and effectively to various external challenges, strengthening the immune system.
Thymosin Alpha 1 (Tα1)
As an immunomodulatory peptide, Tα1 affects cellular signaling cascades associated with TLR/NF-κB and interferon-dependent transcription, modulating the expression of cytokines and antigen-presenting functions in cells of the innate and adaptive immune system (review data in Wikipedia and PubMed).
Mechanism of action (research context)
Tα1 is a thymic peptide (28 amino acids), studied for effects on dendritic cells, NK cells and T-lymphocyte responses, including enhancement of antigen presentation (MHC) and functional polarization of cytokine profiles. In experimental designs it is used to model innate-adaptive interfaces and to test combined regimens with signaling agonists/adjuvants, with clearly defined readouts (e.g. IFN-α/γ, IL-2/IL-12, phenotyping by flow cytometry).
Clinical/preclinical data
| Publicly available sources that report numerical endpoints are heterogeneous in indications and design; to correctly cite specific numerical results, selection of particular publications/indications from PubMed is necessary. Regulatory summaries can be checked at EMA and FDA, where applicable. |
Laboratory and clinical setting
In the laboratory: suitable for in vitro stimulation and ex vivo analysis of human PBMC, as well as for animal models with tracking of transcriptional signatures and functional immune assays. In the clinical setting: use is subject to local regulation and protocols; this material is for educational purposes only.
Pharmacokinetics (for experimental design)
As a peptide, Tα1 is typically considered to have a short plasma profile and requires repeated dosing in protocols; it is recommended to plan time points for early signaling markers (hours) and later functional readouts (days).
Purity and specification
Thymosin Alpha 1 на MyPeptid has a purity >99%, which supports reproducibility in bioanalytical tests, LC-MS verification and validation of biological effects at low concentrations.
Formula: C129H215N33O55
For sale only for educational and research purposes, not for clinical use in humans.
Similar
